EGFR and lung adenocarcinoma: The most common secondary mutation found in lung adenocarcinomas after first or second-generation TKIs was the EGFR T790M mutation in exon 20 (accounting for 50%–60%).[7,8]EGFR T854A mutation is rare, accounting for 0.06% of Chinese NSCLC patients.